Brainstorm Cell Therapeutics Inc (BCLI)

0.53 ↓0.01 (-2.39%)
As of April 25, 2024, 3:52pm EST.

BCLI Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $0.15 - $3.20
  • Market Capitalization: $37.25M
  • Short Percentage: 2.05%
  • Target Price: $2.50
  • Shares Outstanding: 68.34M
  • Next Earnings: Feb 3
View More Stats

Catalysts

DateCategoryCatalyst
2022-02-03
Earnings

BCLI released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $3.10 Close: -1.61% Next Day: +0.32% Next Week: +4.19% View More
0 Comments Share
Help your fellow traders

Stock Details

  • Current Price: $0.53
  • 52-Week Low: $0.15
  • 52-Week High: $3.20
  • Most Recent Quarter: 2024-03-31
  • Shares Float: 61.06M
  • Shares Outstanding: 68.34M
  • Market Capitalization: $37.25M
  • Next Earnings Date: 2022-02-03

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 2.05%

The short interest for Brainstorm Cell Therapeutics Inc is at 2.05%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 80.85%
Insiders: 13.16%
Instutitions: 5.99%

Analyst Target Price

2.50

Brainstorm Cell Therapeutics Inc is currently $1.96 below Wallstreet Analysts' price target.

Yesterday's Volume

274,870

Interest in Brainstorm Cell Therapeutics Inc has been trending down. The average daily volume in the past 14 days is 1,085,379.

Discussions

Please log in or register to share your thoughts.

4texin1/22/24 12:00am

$BCLI cup and handle dont play

0 Like Report
BretJohns9/1/23 05:41pm

$BCLI my hands are made out of diamonds

0 Like Report